Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies (Q28254167)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies	scientific article

Statements

scholarly article

0 references

Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies (English)

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

ChEBI release 2020-05-28

author name string

Mona Darwish

1

0 references

Mary Kirby

2

0 references

Edward T Hellriegel

3

0 references

Philmore Robertson

4

0 references

language of work or name

0 references

publication date

2009

0 references

Clinical Drug Investigation

0 references

29

0 references

9

0 references

613-23

0 references

Clinical pharmacokinetic profile of modafinil

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of steady-state plasma concentrations of armodafinil and modafinil late in the day following morning administration: post hoc analysis of two randomized, double-blind, placebo-controlled, multiple-dose studies in healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11315280-000000000-00000

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28254167&oldid=1987822055"